Marina Viktorovna Bazarova
Research Subjects
Research Interests
Marina Viktorovna Bazarova has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana V. Smetanina
City Clinical Hospital named after V.P. Demikhov
9 shared publications - Irina Sergeevna Kruzhkova
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
5 shared publications - Liliya N. Merkulova
N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology
5 shared publications - Lyudmila Vasilievna Kolobukhina
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
5 shared publications - Aleksandra G. Rosatkevich
National Research Centre of Epidemiology and Microbiology
4 shared publications - Elena I. Burtseva
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
4 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 71 (1) , 32-41
Results of a blood serum examination of residents of Moscow and the Moscow region after the end of the West Nile fever outbreak in 2021
The aim of this study was to determine the level of humoral immunity to the West Nile virus (WNV) in the Moscow region population after the end of the outbreak in October 2021, as well as to confirm the specificity of antibodies to WNV by comparatively testing patient sera for antibodies to the antigenically related endemic tick-borne encephalitis orthoflavivirus (TBEV) using ELISA-IgM, ELISA-IgG, and 50% plaque reduction neutralization test. Materials and methods. We analyzed 1,594 sera from outpatients-residents of Moscow and the surrounding region–who underwent outpatient examination in the winter of 2021 at Infectious Diseases Clinical Hospital No. 1 in Moscow (IKB No. 1) and medical institutions of the Moscow Regional Research Institute named after M.F. Vladimirsky Regional Research Institute (MONIKI) conducted a study without any connection to WNV infection in the summer-autumn of 2021. Results. All samples were negative in ELISA-IgM test with WNV and TBEV antigens. In an ELISA-IgG test with the WNV antigen, antibodies were detected in 64 samples (4.0%). All samples were tested for IgG antibodies to TBEV in an ELISA and neutralizing antibodies to WNV and TBEV in a 50% plaque reduction neutralization test. Specific antibodies to WNV were detected in 44 samples (68.8%), to TBEV in eleven (17.2%), and group-specific antibodies in nine (14.0%). According to the total data from the test of 1,594 sera from residents of the Moscow region, specific antibodies to WNV were detected in 2.8% of cases, to TBEV in 0.7%, and group-specific antibodies in 0.6%. Ten of the 11 individuals with specific IgG antibodies to TBEV were undergoing outpatient examination at Moscow’s Infectious Diseases Clinical Hospital No. 1 for a history of tick-borne encephalitis or for post-vaccination immunity testing following vaccination against this infection. The detection rate of specific antibodies to WNV in similar studies conducted in the same region in 2013 was 0.2%, while in 2021 it was 2.8%. The difference between these rates is statistically significant (p 0.01). Conclusion. Based on these data, it can be concluded that sporadic undiagnosed cases of WNV infection occurred in Moscow and the surrounding region between 2013 and 2021.
- 28 February 2026
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 71 (1) , 32-41
Open AccessResults of a blood serum examination of residents of Moscow and the Moscow region after the end of the West Nile fever outbreak in 2021
The aim of this study was to determine the level of humoral immunity to the West Nile virus (WNV) in the Moscow region population after the end of the outbreak in October 2021, as well as to confirm the specificity of antibodies to WNV by comparatively testing patient sera for antibodies to the antigenically related endemic tick-borne encephalitis orthoflavivirus (TBEV) using ELISA-IgM, ELISA-IgG, and 50% plaque reduction neutralization test. Materials and methods. We analyzed 1,594 sera from outpatients-residents of Moscow and the surrounding region–who underwent outpatient examination in the winter of 2021 at Infectious Diseases Clinical Hospital No. 1 in Moscow (IKB No. 1) and medical institutions of the Moscow Regional Research Institute named after M.F. Vladimirsky Regional Research Institute (MONIKI) conducted a study without any connection to WNV infection in the summer-autumn of 2021. Results. All samples were negative in ELISA-IgM test with WNV and TBEV antigens. In an ELISA-IgG test with the WNV antigen, antibodies were detected in 64 samples (4.0%). All samples were tested for IgG antibodies to TBEV in an ELISA and neutralizing antibodies to WNV and TBEV in a 50% plaque reduction neutralization test. Specific antibodies to WNV were detected in 44 samples (68.8%), to TBEV in eleven (17.2%), and group-specific antibodies in nine (14.0%). According to the total data from the test of 1,594 sera from residents of the Moscow region, specific antibodies to WNV were detected in 2.8% of cases, to TBEV in 0.7%, and group-specific antibodies in 0.6%. Ten of the 11 individuals with specific IgG antibodies to TBEV were undergoing outpatient examination at Moscow’s Infectious Diseases Clinical Hospital No. 1 for a history of tick-borne encephalitis or for post-vaccination immunity testing following vaccination against this infection. The detection rate of specific antibodies to WNV in similar studies conducted in the same region in 2013 was 0.2%, while in 2021 it was 2.8%. The difference between these rates is statistically significant (p 0.01). Conclusion. Based on these data, it can be concluded that sporadic undiagnosed cases of WNV infection occurred in Moscow and the surrounding region between 2013 and 2021.
- 25 October 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (5)
Clinical case of severe foodborne botulism in a child: diagnostic difficulties and treatment tactics
Practitioners’ alertness of botulism in children decreases due to the rarity of its cases. Early diagnosis is based on clinical symptoms though the clinical manifestations may also escalate rapidly and further lead to misdiagnosis. Patients with suspected botulism require immediate hospitalization due to the high risk for paralysis of respiratory muscles and the need for mechanical ventilation. The timely administration of the antitoxin is crucial. However, maximum allowable time of its administration counting from the onset is still a subject to discussion among physicians. Authors represent a clinical case of late diagnosis of severe foodborne botulism in a 5 y/o pediatric patient with the development of tetraplegia, paralysis of cranial nerves, mechanical ventilation for 148 days, the beginning of motor recovery on the 10th day and antitoxin administration on the 18th day counting from the onset of paralysis that all let to the full motor recovery after 20 months. The difficulties of diagnosis in the acute period and both laboratory and instrumental studies are described. The questions of the duration and the necessity of the administration of botulinum antitoxin in this particular clinical case of late diagnosis are discussed as well.
- 25 October 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (5)
Clinical case of severe foodborne botulism in a child: diagnostic difficulties and treatment tactics
Practitioners’ alertness of botulism in children decreases due to the rarity of its cases. Early diagnosis is based on clinical symptoms though the clinical manifestations may also escalate rapidly and further lead to misdiagnosis. Patients with suspected botulism require immediate hospitalization due to the high risk for paralysis of respiratory muscles and the need for mechanical ventilation. The timely administration of the antitoxin is crucial. However, maximum allowable time of its administration counting from the onset is still a subject to discussion among physicians. Authors represent a clinical case of late diagnosis of severe foodborne botulism in a 5 y/o pediatric patient with the development of tetraplegia, paralysis of cranial nerves, mechanical ventilation for 148 days, the beginning of motor recovery on the 10th day and antitoxin administration on the 18th day counting from the onset of paralysis that all let to the full motor recovery after 20 months. The difficulties of diagnosis in the acute period and both laboratory and instrumental studies are described. The questions of the duration and the necessity of the administration of botulinum antitoxin in this particular clinical case of late diagnosis are discussed as well.
- Open Access
- 1 June 2023
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 28 (2) , 67-77
Epidemic season 2021–2022: Frequency of co-infection by respiratory viral pathogens
BACKGROUND: This study was conducted to determine the characteristics of various viral respiratory pathogens spreading during the epidemic season 20212022 and the frequency of co-infection with SARS-CoV-2 and influenza. AIM: To assess the development of the influenza epidemic and frequency of cases of co-infection with respiratory pathogens in patients with acute respiratory viral infections between 2021 and 2022. MATERIALS AND METHODS: Traditional and hospital epidemiological surveillance methods for acute respiratory viral infections were used. RESULTS: The epidemic season of 20212022 was characterized by the early activity of the influenza A(H3N2) virus and the emergence and rapid spread of the omicron variant of SARS-CoV-2. The distribution of different respiratory pathogens during the epidemic season 20212022 was clearly traced: SARS-CoV-2 (18.8%) was predominant, followed by influenza viruses (10.6%) and pathogens of other acute respiratory viral infections (0.43.7%). With respect to influenza A (H3N2) and B viruses, the heterogeneity of their populations and drift variability in relation to vaccine strains were noted. DISCUSSION: The frequency of co-infection with various respiratory pathogens was low, i.e., it was no more than 0.1%according to traditional surveillance, and no more than 9.2% in the hospital surveillance. The rationale for updating the composition of influenza vaccines for the countries in the Northern Hemisphere for 20222023 season was identified. CONCLUSION: At present, early diagnosis of influenza is important given the availability of effective drugs with a direct mechanism of action for the prevention and treatment of this pathogen. Timely use of anti-influenza drugs will reduce the risks of a severe course, complications, and death, including co-infection with SARS-CoV-2.
- 1 June 2023
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 28 (2) , 67-77
Open AccessEpidemic season 2021–2022: Frequency of co-infection by respiratory viral pathogens
BACKGROUND: This study was conducted to determine the characteristics of various viral respiratory pathogens spreading during the epidemic season 20212022 and the frequency of co-infection with SARS-CoV-2 and influenza. AIM: To assess the development of the influenza epidemic and frequency of cases of co-infection with respiratory pathogens in patients with acute respiratory viral infections between 2021 and 2022. MATERIALS AND METHODS: Traditional and hospital epidemiological surveillance methods for acute respiratory viral infections were used. RESULTS: The epidemic season of 20212022 was characterized by the early activity of the influenza A(H3N2) virus and the emergence and rapid spread of the omicron variant of SARS-CoV-2. The distribution of different respiratory pathogens during the epidemic season 20212022 was clearly traced: SARS-CoV-2 (18.8%) was predominant, followed by influenza viruses (10.6%) and pathogens of other acute respiratory viral infections (0.43.7%). With respect to influenza A (H3N2) and B viruses, the heterogeneity of their populations and drift variability in relation to vaccine strains were noted. DISCUSSION: The frequency of co-infection with various respiratory pathogens was low, i.e., it was no more than 0.1%according to traditional surveillance, and no more than 9.2% in the hospital surveillance. The rationale for updating the composition of influenza vaccines for the countries in the Northern Hemisphere for 20222023 season was identified. CONCLUSION: At present, early diagnosis of influenza is important given the availability of effective drugs with a direct mechanism of action for the prevention and treatment of this pathogen. Timely use of anti-influenza drugs will reduce the risks of a severe course, complications, and death, including co-infection with SARS-CoV-2.
- Open Access
- 16 November 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (4) , 322-330
Characteristics of imported cases of Dengue fever and hemorrhagic Dengue fever in 2009–2019
Introduction. In Russia, the approved morbidity statistics system is represented by the International Classification of Diseases of the 10th revision (ICD-10). This classification provides two forms of dengue fever (DF): dengue fever (A90) and hemorrhagic dengue (A91). Official statistics on the ratio of forms of DF is not published in open sources and this lack of information about the real ratio of the forms of DF makes it difficult to objectively assess the factors that determine the severity of this disease. The aim: compare the clinical and epidemiological features of dengue fever and hemorrhagic dengue fever in patients hospitalized in 20092019 to the City Infectious Clinical Hospital No. 1, Moscow. Materials and methods. A retrospective cohort study. We analyzed the patient database and reviewed 391 medical records of patients with diagnosed dengue fever. We compared gender, age characteristics, travel geography including information about previous visits of patients to endemic regions and dengue virus serotype. To determine the primary and re-infection rate, an analysis of IgG for the dengue virus was carried out on days 15 of the disease. To compare indicators, 95% confidence intervals for proportions, medians, and interquartile ranges were calculated. The significance of differences between independent samples for assessing qualitative characteristics was carried out using the criteria 2, the odds ratio. To assess the quantitative characteristics, the Mann-Whitney test was used. Differences were considered statistically significant at p 0.05. Results. The proportion of patients with dengue fever was 14.9% of all hospitalized with febrile illnesses that developed after international travel. Hemorrhagic dengue fever (DHF) was diagnosed in 15.7% of patients with dengue fever. DHF developed significantly more often in women, as well as in those who had history of repeated visits to endemic regions. However, DHF was also diagnosed in 10.9% of first-time travelers to tropical countries. We did not find significant differences in the rates of DHF development depending on age and dengue virus serotype. In a number of patients who had not previously traveled to endemic regions, IgG to the dengue virus were detected, which may indicate a previous infection with related flaviviruses. Conclusion. It has been established that in the regions most visited by Russians, there is a circulation of all serotypes of the dengue virus with an annual change in the predominant serotype.
- 16 November 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (4) , 322-330
Open AccessCharacteristics of imported cases of Dengue fever and hemorrhagic Dengue fever in 2009–2019
Introduction. In Russia, the approved morbidity statistics system is represented by the International Classification of Diseases of the 10th revision (ICD-10). This classification provides two forms of dengue fever (DF): dengue fever (A90) and hemorrhagic dengue (A91). Official statistics on the ratio of forms of DF is not published in open sources and this lack of information about the real ratio of the forms of DF makes it difficult to objectively assess the factors that determine the severity of this disease. The aim: compare the clinical and epidemiological features of dengue fever and hemorrhagic dengue fever in patients hospitalized in 20092019 to the City Infectious Clinical Hospital No. 1, Moscow. Materials and methods. A retrospective cohort study. We analyzed the patient database and reviewed 391 medical records of patients with diagnosed dengue fever. We compared gender, age characteristics, travel geography including information about previous visits of patients to endemic regions and dengue virus serotype. To determine the primary and re-infection rate, an analysis of IgG for the dengue virus was carried out on days 15 of the disease. To compare indicators, 95% confidence intervals for proportions, medians, and interquartile ranges were calculated. The significance of differences between independent samples for assessing qualitative characteristics was carried out using the criteria 2, the odds ratio. To assess the quantitative characteristics, the Mann-Whitney test was used. Differences were considered statistically significant at p 0.05. Results. The proportion of patients with dengue fever was 14.9% of all hospitalized with febrile illnesses that developed after international travel. Hemorrhagic dengue fever (DHF) was diagnosed in 15.7% of patients with dengue fever. DHF developed significantly more often in women, as well as in those who had history of repeated visits to endemic regions. However, DHF was also diagnosed in 10.9% of first-time travelers to tropical countries. We did not find significant differences in the rates of DHF development depending on age and dengue virus serotype. In a number of patients who had not previously traveled to endemic regions, IgG to the dengue virus were detected, which may indicate a previous infection with related flaviviruses. Conclusion. It has been established that in the regions most visited by Russians, there is a circulation of all serotypes of the dengue virus with an annual change in the predominant serotype.
- Open Access
- 13 September 2022
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (4) , 16-26
Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021
Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article uses methods used in epidemiological surveillance of acute respiratory viral infections. Results and discussion. The results of the diagnostic available ARVI pathogens monitoring during epidemic seasons 2018-2021 are presented. The tendency of greater engagement of aged group 15 y.o. and older in epidemic process by morbidity and hospitalization due to SARI was shown. 49 818 nasal swabs from patients with influenza infection, 36 044 – with ARVI and 59 062 – with SARS-CoV-2 were tested. The top three in the structure of ARVI were INF, HEV-D and HRSV (in the 2018–2019 season); INF, SARS-CoV-2 and HEV-D (2019–2020); SARS-CoV-2, HEV-D and HPIV/HCoV (2020–2021). The activity of viral pathogens also differed: for HPIV, HAdV, HEV-D, HMPV, a decrease in activity was noted during the appearance of SARS-CoV-2 (2019–2020) and some of its growth in the following season; in relation to HRSV and INF - a decrease in activity during the last two seasons, and for INF – extremely low activity in the 2020-2021 season; the activity of seasonal HCoV even increased slightly. The data of genetic analyses of SARS-CoV-2 positive samples showed the heterogeneity of its population with a representative of variants (Alfa, Delta) as well as endemic for Russia and Moscow variants only. The recommended composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season and in the 2022 southern hemisphere influenza season are presented due to their drift changeability. Conclusions. SARS-CoV-2 was influenced by the activity of ARVI pathogens with the almost complete displacement of influenza viruses from the circulation in the period 2020–2021.
- 13 September 2022
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (4) , 16-26
Open AccessFeatures of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021
Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article uses methods used in epidemiological surveillance of acute respiratory viral infections. Results and discussion. The results of the diagnostic available ARVI pathogens monitoring during epidemic seasons 2018-2021 are presented. The tendency of greater engagement of aged group 15 y.o. and older in epidemic process by morbidity and hospitalization due to SARI was shown. 49 818 nasal swabs from patients with influenza infection, 36 044 – with ARVI and 59 062 – with SARS-CoV-2 were tested. The top three in the structure of ARVI were INF, HEV-D and HRSV (in the 2018–2019 season); INF, SARS-CoV-2 and HEV-D (2019–2020); SARS-CoV-2, HEV-D and HPIV/HCoV (2020–2021). The activity of viral pathogens also differed: for HPIV, HAdV, HEV-D, HMPV, a decrease in activity was noted during the appearance of SARS-CoV-2 (2019–2020) and some of its growth in the following season; in relation to HRSV and INF - a decrease in activity during the last two seasons, and for INF – extremely low activity in the 2020-2021 season; the activity of seasonal HCoV even increased slightly. The data of genetic analyses of SARS-CoV-2 positive samples showed the heterogeneity of its population with a representative of variants (Alfa, Delta) as well as endemic for Russia and Moscow variants only. The recommended composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season and in the 2022 southern hemisphere influenza season are presented due to their drift changeability. Conclusions. SARS-CoV-2 was influenced by the activity of ARVI pathogens with the almost complete displacement of influenza viruses from the circulation in the period 2020–2021.
- Open Access
- 1 September 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (3) , 202-208
Development of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
Introduction. The increase in the incidence of whooping cough in children and adults of different age groups justifies the need for their revaccination and the development of new, acceptable for these purposes. This work is devoted to substantiating the design of a clinical trial and describing the results of a comparative study of the safety and tolerability of the drug "GamLPV" with two-fold intranasal administration to healthy adult volunteers using two methods. The choice of the scheme and method of administration of the drug is justified. The serological structure of the population of adults aged 18–40 years living in Moscow and the Moscow region is characterized.Aim. Determination of the safety and tolerability of the drug with a double intranasal administration of the vaccine by drip method and spraying through an actuator.Materials and methods. A randomized placebo-controlled trial included 50 healthy male and female volunteers aged 18 to 40 years who met the inclusion criteria. The volunteers were divided into 2 groups of 25 people: a drip method of administration and spraying through an "actuator". By both methods, the drug was administered twice with an interval of 60 days.Results and discussion. Serological analysis of the population of healthy volunteers at the prescreening stage justified the inclusion in the study of volunteers containing anti-pertussis antibodies in the blood (IgG ≤40 Ed/ml). A comparison of the results of preclinical studies on an experimental model of non-human monkeys and the first phase of a clinical study of GamLPV allowed us to propose two methods of double administration of the drug as a promising vaccination scheme for volunteers. A comparative randomized study shows the safety of using the proposed scheme for vaccination of adult volunteers.Conclusions. Both proposed methods of double administration can be used to plan a multicenter study to research the immunogenicity and protective activity of GamLPV.
- 1 September 2022
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (3) , 202-208
Open AccessDevelopment of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
Introduction. The increase in the incidence of whooping cough in children and adults of different age groups justifies the need for their revaccination and the development of new, acceptable for these purposes. This work is devoted to substantiating the design of a clinical trial and describing the results of a comparative study of the safety and tolerability of the drug "GamLPV" with two-fold intranasal administration to healthy adult volunteers using two methods. The choice of the scheme and method of administration of the drug is justified. The serological structure of the population of adults aged 18–40 years living in Moscow and the Moscow region is characterized.Aim. Determination of the safety and tolerability of the drug with a double intranasal administration of the vaccine by drip method and spraying through an actuator.Materials and methods. A randomized placebo-controlled trial included 50 healthy male and female volunteers aged 18 to 40 years who met the inclusion criteria. The volunteers were divided into 2 groups of 25 people: a drip method of administration and spraying through an "actuator". By both methods, the drug was administered twice with an interval of 60 days.Results and discussion. Serological analysis of the population of healthy volunteers at the prescreening stage justified the inclusion in the study of volunteers containing anti-pertussis antibodies in the blood (IgG ≤40 Ed/ml). A comparison of the results of preclinical studies on an experimental model of non-human monkeys and the first phase of a clinical study of GamLPV allowed us to propose two methods of double administration of the drug as a promising vaccination scheme for volunteers. A comparative randomized study shows the safety of using the proposed scheme for vaccination of adult volunteers.Conclusions. Both proposed methods of double administration can be used to plan a multicenter study to research the immunogenicity and protective activity of GamLPV.
- 30 January 2022
- Published by PANORAMA Publishing House in Sanitarnyj vrač (Sanitary Doctor)
- No. 2,p. 111-120
Epidemiological traits of measles in infectious hospital staff
The maximum incidence rates of measles were recorded on the eve of the development of the COVID-19 pandemic in 2019 in many countries of the world, including Russia. One of the features of the epidemic process of this infection in the period from 2011 to 2019 was the involvement of employees of medical organizations (MO) with the formation of large foci. Current features for the development of the measles epidemic situation can be assessed using serological studies. Aim: to assess the epidemiological features of measles in medical workers in Moscow, including by assessing the prevalence of specific IgG antibodies to the measles virus using the example of an infectious disease’s hospital in Moscow. Materials and methods. Using data from state reports on the sanitary and epidemiological well-being of the population in Moscow and form No. 2 of the Federal State Statistical Observation «Information on Infectious and Parasitic Diseases». To study the strength of immunity against measles by the method of enzyme-linked immunosorbent assay (ELISA) using test systems «Vecto-measles IgG» (CJSC «Vector-Best», Russia), 191 blood serum samples from the collection of the Department of Epidemiology of the National Research Center for Epidemiology were examined and Microbiology named after Honorary Academician N. F. Gamaleya (Moscow), taken from the employees of the infectious hospital of the city of Moscow (aged 22 to 65 years) with a different vaccination history. Positive (seropositive) was considered the result of a study of the level of IgG antibodies to measles virus more than 0.18 IU / ml. Results. A feature of the epidemic process of measles in Moscow (for the period from 2014 to 2020) was the annual (except for 2016) registration of measles cases among medical workers and hospital patients of various profiles (in 2019–2020, only among patients). Reasonable doubts about the reliability of the vaccination coverage of the population according to official statistics (exceeds the level of 95 % since 2013), including medical workers, arise due to the availability of data on the previous vaccination in some cases of measles. Measles vaccination data were recorded in 28 people (4.7 %) out of 191 surveyed. In two of them, antibodies to the measles virus could not be detected, and the median of their level in seropositive individuals was 1.75 IU / ml (0.5; 3.0). 10 health workers had a history of measles in the past, which was confirmed by serological examination (the level of IgG antibodies was higher than 3.3 IU / ml). 152 people (79.6 %) had no information about vaccination and measles in the past. Among them, eight people were seronegative (5.3 %), and the level of antibodies in the seropositive was higher than in the vaccinated, and amounted to 2.4 IU / ml [0.74; 3.68]. Conclusion. It was found that the proportion of seronegative among the surveyed individuals did not exceed 7 %. However, the predominance of individuals with a low level of immunity, both among vaccinated and unvaccinated individuals, indicates the need for periodic serological studies for the timely detection of seronegative individuals.
- 30 January 2022
- Published by PANORAMA Publishing House in Sanitarnyj vrač (Sanitary Doctor)
- No. 2,p. 111-120
Epidemiological traits of measles in infectious hospital staff
The maximum incidence rates of measles were recorded on the eve of the development of the COVID-19 pandemic in 2019 in many countries of the world, including Russia. One of the features of the epidemic process of this infection in the period from 2011 to 2019 was the involvement of employees of medical organizations (MO) with the formation of large foci. Current features for the development of the measles epidemic situation can be assessed using serological studies. Aim: to assess the epidemiological features of measles in medical workers in Moscow, including by assessing the prevalence of specific IgG antibodies to the measles virus using the example of an infectious disease’s hospital in Moscow. Materials and methods. Using data from state reports on the sanitary and epidemiological well-being of the population in Moscow and form No. 2 of the Federal State Statistical Observation «Information on Infectious and Parasitic Diseases». To study the strength of immunity against measles by the method of enzyme-linked immunosorbent assay (ELISA) using test systems «Vecto-measles IgG» (CJSC «Vector-Best», Russia), 191 blood serum samples from the collection of the Department of Epidemiology of the National Research Center for Epidemiology were examined and Microbiology named after Honorary Academician N. F. Gamaleya (Moscow), taken from the employees of the infectious hospital of the city of Moscow (aged 22 to 65 years) with a different vaccination history. Positive (seropositive) was considered the result of a study of the level of IgG antibodies to measles virus more than 0.18 IU / ml. Results. A feature of the epidemic process of measles in Moscow (for the period from 2014 to 2020) was the annual (except for 2016) registration of measles cases among medical workers and hospital patients of various profiles (in 2019–2020, only among patients). Reasonable doubts about the reliability of the vaccination coverage of the population according to official statistics (exceeds the level of 95 % since 2013), including medical workers, arise due to the availability of data on the previous vaccination in some cases of measles. Measles vaccination data were recorded in 28 people (4.7 %) out of 191 surveyed. In two of them, antibodies to the measles virus could not be detected, and the median of their level in seropositive individuals was 1.75 IU / ml (0.5; 3.0). 10 health workers had a history of measles in the past, which was confirmed by serological examination (the level of IgG antibodies was higher than 3.3 IU / ml). 152 people (79.6 %) had no information about vaccination and measles in the past. Among them, eight people were seronegative (5.3 %), and the level of antibodies in the seropositive was higher than in the vaccinated, and amounted to 2.4 IU / ml [0.74; 3.68]. Conclusion. It was found that the proportion of seronegative among the surveyed individuals did not exceed 7 %. However, the predominance of individuals with a low level of immunity, both among vaccinated and unvaccinated individuals, indicates the need for periodic serological studies for the timely detection of seronegative individuals.
- 13 December 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (6)
CRIMEAN HAEMORRHAGIC FEVER IN A CHILD AFTER A VISIT TO CRIMEA
This article contains additional information on the features of the clinical picture of Crimean hemorrhagic fever (CHF) in children, the ongoing activity of CHF virus circulation in the territory of the Republic of Crimea, confirms the possibility of imported cases of CHF in non-endemic regions, which is associated with the likely risks of nosocomial and intrafamilial cases of this infection. The data on the course of the disease, clinical and laboratory diagnostic examination of a child infected with CHF in the Crimea are presented.
- 13 December 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (6)
CRIMEAN HAEMORRHAGIC FEVER IN A CHILD AFTER A VISIT TO CRIMEA
This article contains additional information on the features of the clinical picture of Crimean hemorrhagic fever (CHF) in children, the ongoing activity of CHF virus circulation in the territory of the Republic of Crimea, confirms the possibility of imported cases of CHF in non-endemic regions, which is associated with the likely risks of nosocomial and intrafamilial cases of this infection. The data on the course of the disease, clinical and laboratory diagnostic examination of a child infected with CHF in the Crimea are presented.
- Open Access
- 7 January 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 65 (6) , 335-349
Peculiarities of the influenza and ARVI viruses circulation during epidemic season 2019–2020 in some regions of Russia
Introduction. The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019–2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019.Material and methods. The data of epidemiological surveillance on influenza- and ARVI-associated morbidity and hospitalization in different age groups of population were analyzed; virological, genetic and statistical methods were used.Results. Preschool children were involved in epidemic the most. Meanwhile, the highest rate of hospitalization was observed in patients of 18–40 years old. Influenza A(H1N1)pdm09 virus dominated in etiology of ARVI in hospitalized patients and pneumonia. The role of respiratory viruses in severe cases of pneumonia and bronchoalveolar syndrome in children was shown. The differences in spectrum of circulating viruses caused ARVI in different regions of Russia were found. Influenza A(H1N1)pdm09 and B/Victoria-like viruses were the main etiological agents that caused of epidemic; its activity among all ARVI was 7.3 and 8.0%, respectively. The differences in antigenic properties of influenza A(H3N2) and B epidemic strains compared to vaccine viruses were found. The populations of epidemic strains were presented by following dominant genetic groups: 6B1.A5/183P for A(H1N1)pdm09, 3С.2а1b+137F for A(H3N2) and V1A.3 line B/Victoria-like for B viruses. The good profile of epidemic strains susceptibility to anti-neuraminidase inhibitors has been saved. The most of the studied influenza strains had the receptor specificity characteristic of human influenza viruses.Conclusions. Obtained results identified the peculiarities of viruses caused the influenza and ARVI in epidemic season 2019–2020 in different regions of Russia. These results suggested the important role of influenza A(H1N1) pdm09 in severe cases and pneumonia in adults 18–40 years old. The continuing drift in influenza viruses was found, which, apparently, could not but affect the efficacy of vaccine prophylaxis and was also considered in the recommendations of WHO experts on the composition of influenza vaccines for the countries of the Northern Hemisphere in the 2020–2021 season.
- 7 January 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 65 (6) , 335-349
Open AccessPeculiarities of the influenza and ARVI viruses circulation during epidemic season 2019–2020 in some regions of Russia
Introduction. The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019–2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019.Material and methods. The data of epidemiological surveillance on influenza- and ARVI-associated morbidity and hospitalization in different age groups of population were analyzed; virological, genetic and statistical methods were used.Results. Preschool children were involved in epidemic the most. Meanwhile, the highest rate of hospitalization was observed in patients of 18–40 years old. Influenza A(H1N1)pdm09 virus dominated in etiology of ARVI in hospitalized patients and pneumonia. The role of respiratory viruses in severe cases of pneumonia and bronchoalveolar syndrome in children was shown. The differences in spectrum of circulating viruses caused ARVI in different regions of Russia were found. Influenza A(H1N1)pdm09 and B/Victoria-like viruses were the main etiological agents that caused of epidemic; its activity among all ARVI was 7.3 and 8.0%, respectively. The differences in antigenic properties of influenza A(H3N2) and B epidemic strains compared to vaccine viruses were found. The populations of epidemic strains were presented by following dominant genetic groups: 6B1.A5/183P for A(H1N1)pdm09, 3С.2а1b+137F for A(H3N2) and V1A.3 line B/Victoria-like for B viruses. The good profile of epidemic strains susceptibility to anti-neuraminidase inhibitors has been saved. The most of the studied influenza strains had the receptor specificity characteristic of human influenza viruses.Conclusions. Obtained results identified the peculiarities of viruses caused the influenza and ARVI in epidemic season 2019–2020 in different regions of Russia. These results suggested the important role of influenza A(H1N1) pdm09 in severe cases and pneumonia in adults 18–40 years old. The continuing drift in influenza viruses was found, which, apparently, could not but affect the efficacy of vaccine prophylaxis and was also considered in the recommendations of WHO experts on the composition of influenza vaccines for the countries of the Northern Hemisphere in the 2020–2021 season.
- 1 January 2021
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 10 (4)
West Nile fever on the territory of the Moscow agglomeration
Лихорадка Западного Нила на территории Московской агломерации
- 1 January 2021
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 10 (4)
West Nile fever on the territory of the Moscow agglomeration
Лихорадка Западного Нила на территории Московской агломерации